Source: Mafarki gama gari
Wani bayani da aka buga ranar Alhamis Amnesty International ta zargi babbar kamfanin harhada magunguna Pfizer da yin ikirarin yaudara game da kokarinta na samar da allurar rigakafin Covid-19 ga kasashe masu karamin karfi, yayin da ta tanadi mafi yawan alluran rigakafin ga kasashe masu arziki.
"Pfizer ta ce ta himmatu wajen samar da alluran rigakafi ga kasashe masu karamin karfi da matsakaicin kudin shiga, amma lambobin ba su da tabbacin hakan. Gaskiyar ita ce har yanzu wannan kamfani yana sanya riba a gaba.”
Kungiyar kare hakkin dan adam ta ce "Shekaru biyu bayan bullar cutar sankara ta coronavirus, rabin al'ummar duniya [sun samu] a kalla kashi daya na allurar rigakafin - wani babban ci gaba a kan hanyar yin rigakafin duniya," in ji kungiyar kare hakkin dan Adam. "Duk da haka kashi 96% na mutanen da ke cikin kasashe masu karamin karfi ba a yi musu allurar rigakafi ba."
"Duk da karuwar adadin alluran rigakafin da ake samarwa, jihohi da kamfanonin harhada magunguna suna ci gaba da kasa ba da tabbacin samun isasshen magunguna na ceton rai ga kowa," in ji sanarwar.
"Pfizer, daya daga cikin masu samar da alluran rigakafi mafi girma kuma mafi riba… ya kawo sama da allurai biliyan 1.8 zuwa yau," in ji littafin. "Duk da alkawuran da ta yi - wasu da aka zarge su da yaudara - Pfizer… yana ci gaba da adana yawancin alluran rigakafinsa ga kasashe masu samun kudin shiga."
Rahoton ya lura cewa kamfanin yana "har yanzu yana ƙin shiga cikin shirye-shiryen raba fasaha, kamar cibiyar fasahar mRNA ta [Kungiyar Lafiya ta Duniya] ta Afirka ta Kudu, kuma ta himmatu sosai kan ƙoƙarin ɗaukar takunkumin mallakar fasaha."
"Tare da hasashen samun dalar Amurka biliyan 36 daga alluran rigakafi na 2021, Pfizer har yanzu yana sanya riba a gaban mutane," in ji Amnesty.
Dangane da taƙaitaccen bayanin, da'awar Pfizer na cewa maganin ta na coronavirus "zai kasance ga kowane mara lafiya, ƙasa, da al'ummar da ke neman dama," kuma fifikon kamfanin shine "rarrabuwar gaskiya da adalci" na allurai, yaudara ne.
A cikin watan Yuni 2021 wasiƙar zuwa ga Amnesty, Pfizer ya yi alƙawarin "samar da allurai biliyan biyu na rigakafin Covid-19 ga ƙasashe masu matsakaici da masu karamin karfi a cikin watanni 18 masu zuwa," da kuma isar da kashi 40% na shirin samar da allurar rigakafin ga irin waɗannan ƙasashe. .
"Wannan iƙirarin yana ba da ra'ayi cewa ƙasashe masu karamin karfi suna karɓar kaso mai tsoka na allurar Pfizer, amma harshe na yaudara ne," in ji sanarwar. "Pfizer ya hade kasashe masu karamin karfi, na tsakiya, da na sama - sama da kashi 84% na al'ummar duniya - zuwa rukuni daya kuma suna kiran su 'ƙananan da matsakaicin kudin shiga'. A cikin wannan nau'i mai fa'ida, yawancin allurai na Pfizer a zahiri suna zuwa 'kasashe na tsakiya' masu samun kudin shiga kamar Malaysia, Mexico, da Thailand. "
Bugu da kari, yayin da Pfizer ya ce ya aika da alluran rigakafin biliyan biyu a karshen watan Satumba, kamfanin ya amince da Amnesty a watan Nuwamba cewa allurai miliyan 154 ne kawai, ko kasa da kashi 8% na jimillar sa - an aika zuwa 42 low da ƙananan tsakiya. - Kasashe masu samun kudin shiga, kuma kasa da kashi 10% na wadanda aka harbe sun tafi kasashe masu karamin karfi.
Bugu da ƙari, yayin da Pfizer ya yi iƙirarin cewa "ya himmatu don raba kayan aikin kimiyya da fahimtarmu, ƙwarewar haɓakawa, da ƙarfin masana'antu," bayanin taƙaitaccen bayanin kamfanin ya ce "ya yi adawa da raba kayan fasaha ta hanyar Pool na Fasaha ta WHO ta Covid-19 (C-TAP). ) kuma bai shiga sabuwar cibiyar musayar fasahar rigakafin cutar ta Covid-19 mRNA a Afirka ta Kudu ba."
Amnesty ta kuma lura cewa Pfizer ya soki gwamnatin Biden don adawa da shawarwarin da Indiya da Afirka ta Kudu suka gabatar ga Hukumar Kasuwanci ta Duniya don Abubuwan da suka danganci Ciniki na Haƙƙin Haƙƙin Haƙƙin Hankali (TRIPS) don dakatar da mahimman abubuwan mallakar fasaha na Yarjejeniyar TAFIYA. wanda ya bayyana a matsayin abin da zai hana saka hannun jari da kirkire-kirkire.”
Patrick Wilcken, shugaban kungiyar Amnesty ta kasuwanci da kare hakkin dan adam. ya ce A cikin wata sanarwa a ranar Alhamis cewa "Pfizer ta ce ta himmatu wajen samar da allurai ga kasashe masu karamin karfi da matsakaicin kudin shiga, amma lambobin ba su da tabbacin hakan. Gaskiyar ita ce har yanzu wannan kamfani yana sanya riba a gaba.”
Ya ci gaba da cewa, "Kamar yadda wadannan kamfanoni za su so su yi amfani da bayanan gaskiya, lambobin a bayyane suke - har yanzu suna ba da mafi yawan alluran rigakafin su ga sassan duniya masu wadata," in ji shi.
Wilcken ya kara da cewa "Har yanzu muna cikin wani yanayi na rashin lafiya da kuma rikicin kare hakkin dan Adam da ba a taba ganin irinsa ba a duniya, kuma yana da matukar muhimmanci dukkan kasashen duniya su sami damar yin rigakafin da wuri."
ZNetwork ana samun kuɗi ta hanyar karimcin masu karatun sa.
Bada Tallafi